vTv Therapeutics adds federal forum clause for Securities Act claims in bylaw update

PUBT · 3d ago
vTv Therapeutics adds federal forum clause for Securities Act claims in bylaw update
  • vTv Therapeutics adopted third amended and restated bylaws on Oct. 1, 2026.
  • Director nominations tightened, requiring Rule 14a-19 compliance evidence at least five business days before meetings.
  • Voting standard changed for non-director matters to a majority of voting power cast for or against.
  • Federal U.S. district courts designated as exclusive forum for Securities Act claims, absent written consent to another venue.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. vTv Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641489-26-000032), on October 06, 2026, and is solely responsible for the information contained therein.